CoChat

Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review

Open access
Wu, Kun-Chi, Chang, Yu-Hsun, Ding, Dah-Ching, Lin, Shinn-Zong · 2024 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.

Abstract

Cartilage degeneration is a key feature of aging and osteoarthritis, characterized by the progressive deterioration of joint function, pain, and limited mobility. Current treatments focus on symptom relief, not cartilage regeneration. Mesenchymal stromal cells (MSCs) offer a promising therapeutic option due to their capability to differentiate into chondrocytes, modulate inflammation, and promote tissue regeneration. This review explores the potential of MSCs for cartilage regeneration, examining their biological properties, action mechanisms, and applications in preclinical and clinical settings. MSCs derived from bone marrow, adipose tissue, and other sources can self-renew and differentiate into multiple cell types. In aging cartilage, they aid in tissue regeneration by secreting growth factors and cytokines that enhance repair and modulate immune responses. Recent preclinical studies show that MSCs can restore cartilage integrity, reduce inflammation, and improve joint function, although clinical translation remains challenging due to limitations such as cell viability, scalability, and regulatory concerns. Advancements in MSC delivery, including scaffold-based approaches and engineered exosomes, may improve therapeutic effectiveness. Potential risks, such as tumorigenicity and immune rejection, are also discussed, emphasizing the need for optimized treatment protocols and large-scale clinical trials to develop effective, minimally invasive therapies for cartilage regeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms252312911

Cites

228 of 228 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Sources, properties, and therapeutic potential of mesenchymal stromal cells (MSCs) for osteoarthritis treatment. MSCs can be derived from adipose tissue, umbilical cord, bone marrow, placenta, and dental pulp. MSCs from these sources exhibit essential characteristics, including self-renewal and multipotency, and respond to specific signaling molecules (e.g., BMP, FGF, TGF-β, IGF-1, SOX9) that aid in their proliferation and differentiation. MSCs also possess immunomodulatory and anti-inflammatory properties, making them suitable for therapeutic applications. Upon differentiation, MSCs can become chondrocytes, cells critical for cartilage formation and maintenance. Chondrocytes produce key ECM components, including type II collagen and aggrecan, which are essential for joint health. The paracrine and immunomodulatory effects of MSCs, along with their differentiation potential, are utilized in treating osteoarthritis to alleviate inflammation, support tissue repair, and restore cartilage function. This approach offers a promising approach for managing joint degenerative diseases.
Figure 1 Sources, properties, and therapeutic potential of mesenchymal stromal cells (MSCs) for osteoarthritis treatment. MSCs can be derived from adipose tissue, umbilical cord, bone marrow, placenta, and dental pulp. MSCs from these sources exhibit essential characteristics, including self-renewal and multipotency, and respond to specific signaling molecules (e.g., BMP, FGF, TGF-β, IGF-1, SOX9) that aid in their proliferation and differentiation. MSCs also possess immunomodulatory and anti-inflammatory properties, making them suitable for therapeutic applications. Upon differentiation, MSCs can become chondrocytes, cells critical for cartilage formation and maintenance. Chondrocytes produce key ECM components, including type II collagen and aggrecan, which are essential for joint health. The paracrine and immunomodulatory effects of MSCs, along with their differentiation potential, are utilized in treating osteoarthritis to alleviate inflammation, support tissue repair, and restore cartilage function. This approach offers a promising approach for managing joint degenerative diseases.CC BY · PubMed Central
Figure 2 Optimal delivery methods for mesenchymal stromal cells (MSCs) in joint regeneration. The three main delivery methods are scaffold, extracellular vesicles, and hydrogels. Scaffolds are porous, supportive structures that enable MSCs to attach and proliferate, thereby maintaining cell viability and providing structural stability at the target site. Extracellular vesicles, which are cell-free particles derived from MSCs, contain signaling molecules (e.g., RNA, proteins) that facilitate tissue repair through intercellular communication, eliminating the need to introduce live cells. Hydrogels, gel-like materials that encapsulate MSCs, provide a hydrated environment that protects cells and enables their gradual release, supporting sustained therapeutic effects. These three delivery methods are directed toward the joint, representing their potential applications in regenerative treatments for conditions like osteoarthritis or cartilage damage. This figure highlights the adaptability of MSC-based therapies and the importance of selecting optimal delivery vehicles to enhance clinical outcomes.
Figure 2 Optimal delivery methods for mesenchymal stromal cells (MSCs) in joint regeneration. The three main delivery methods are scaffold, extracellular vesicles, and hydrogels. Scaffolds are porous, supportive structures that enable MSCs to attach and proliferate, thereby maintaining cell viability and providing structural stability at the target site. Extracellular vesicles, which are cell-free particles derived from MSCs, contain signaling molecules (e.g., RNA, proteins) that facilitate tissue repair through intercellular communication, eliminating the need to introduce live cells. Hydrogels, gel-like materials that encapsulate MSCs, provide a hydrated environment that protects cells and enables their gradual release, supporting sustained therapeutic effects. These three delivery methods are directed toward the joint, representing their potential applications in regenerative treatments for conditions like osteoarthritis or cartilage damage. This figure highlights the adaptability of MSC-based therapies and the importance of selecting optimal delivery vehicles to enhance clinical outcomes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 228 references

Cited by

See all 33

Metadata

Authors
Wu, K.-C., Chang, Y.-H., Ding, D.-C., & Lin, S.-Z.
Affiliations
Tzu Chi University (TW)
Corresponding author
  • Ding, Dah-Ching
  • Lin, Shinn-Zong
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2024-11-30
Volume
25
Issue
23
Pages
12911
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4404903366
Cited by
33
References
228
Citations by year
2026: 22 · 2025: 11
FWCI
2.45
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
NSTC (113-2314-B-303-024)
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
Keywords
mesenchymal stem cells, cartilage regeneration, osteoarthritis, cartilage degeneration, chondrogenic differentiation, growth factor secretion, inflammation modulation, bone marrow-derived MSCs, adipose-derived MSCs, exosomes, tumorigenicity, immune rejection, clinical translation
MeSH terms
Aging, Animals, Cartilage, Cartilage, Articular, Cell Differentiation, Humans, Osteoarthritis, Regeneration, Chondrocytes, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review. https://app.cochat.ai/papers/10.3390/ijms252312911
The paper
Wu, K.-C., Chang, Y.-H., Ding, D.-C., & Lin, S.-Z. (2024). Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312911

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.